Primary Effusion Lymphoma Prognostic Score ( PEL ‐ PS ): A Validated International Prognostic Score in HIV ‐Associated Primary Effusion Lymphoma , American Journal of Hematology, 100, 3, (393 ...

Primary effusion lymphoma is a human herpes virus 8 (HHV-8)-associated large cell lymphoma of body cavities. Detailed large-scale clinicopathological studies are rarely reported, and the ...

Clinical Features and Outcome of Primary Effusion Lymphoma in HIV-Infected Patients: A Single-Institution Study. JCO 21 , 3948-3954 (2003). DOI: 10.1200/JCO.2003.06.013 ...

Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised ...

All cases of primary effusion lymphoma have KSHV infection of tumor cells, and 80% have EBV coinfection. 37,40 Primary effusion lymphoma may arise from KSHV-infected mesothelial cells that ...

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in primary effusion lymphoma, an aggressive type of non-Hodgkin lymphoma caused by infection with the Kaposi ...

A rare and fatal form of aggressive B-cell lymphoma is Primary effusion lymphoma (PEL), which is caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in ...

The research points to effective new treatment options for KSHV-associated cancers, including Kaposi's sarcoma, primary effusion lymphoma, and HHV8-associated multicentric Castleman disease.

Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised ...

Purpose: To describe the clinical features and outcome of HIV-associated primary effusion lymphoma (PEL) and to compare them with those of the other HIV-associated non-Hodgkin’s lymphomas (NHLs).